首页 | 本学科首页   官方微博 | 高级检索  
     


Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial
Authors:Hammer Scott M,Vaida Florin,Bennett Kara K,Holohan Mary K,Sheiner Lewis,Eron Joseph J,Wheat Lawrence Joseph,Mitsuyasu Ronald T,Gulick Roy M,Valentine Fred T,Aberg Judith A,Rogers Michael D,Karol Cheryl N,Saah Alfred J,Lewis Ronald H,Bessen Laura J,Brosgart Carol,DeGruttola Victor,Mellors John W  AIDS Clinical Trials Group Study Team
Affiliation:Department of Medicine,Columbia University College of Physicians and Surgeons, New York, NY (Dr Hammer);Department of Biostatistics, Statistical and Data Analysis Center, HarvardSchool of Public Health, Boston, Mass (Drs Vaida and DeGruttola, and Ms Bennett);AIDS Clinical Trial Group Operations Center, Silver Spring, Md (Ms Holohan);Department of Laboratory Medicine (Dr Sheiner) and Department of Medicine(Dr Aberg), University of California, San Francisco; Department of Medicine,University of North Carolina, Chapel Hill (Dr Eron); Department of Medicine,Indiana University, Bloomington (Dr Wheat); Department of Medicine, Universityof California, Los Angeles (Dr Mitsuyasu); Department of Medicine, Weill MedicalCollege of Cornell University, New York, NY (Dr Gulick); Department of Medicine,New York University, New York (Dr Valentine); Department of Medicine, Universityof Pittsburgh, Pa (Dr Mellors); GlaxoSmithKline, Research Triangle Park, NC(Dr Rogers); Hoffman-LaRoche, Nutley, NJ (Dr Karol); Merck Research Laboratories,Blue Bell, Pa (Dr Saah); Agouron Pharmaceuticals, La Jolla, Calif (Dr Lewis);DuPont Pharmaceuticals, Wilmington, Del (Dr Bessen); and Gilead Sciences,Foster City, Calif (Dr Brosgart). Dr Bessen is now at Bristol-Myers Squibb.
Abstract:
Keywords:
本文献已被 PubMed 等数据库收录!
点击此处可从《》浏览原始摘要信息
点击此处可从《》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号